Nose's swallowing cancer vaccine has already hope to turn into a clinical trial stage in the near future

On January 23, the tumor expert's adviser of World Health Organization constituted a member, medium academician in the section hospital a Yi professor to once say, the nose swallowed cancer vaccine to develop the work has already made breakthrough currently.The research personnel develops two kinds of tissue culture that"the antigen vaccine of the ＥＢ virus film" has already tested and carried on to the human body cancer cell in the animal of to experiment in achieve success, have already hope in turn into a clinical trial stage in the near future.

The virus of ＥＢ has in the nose swallow the cancer occurrence important function.The research discovers that the nose swallows the cancer sufferer's ＥＢ virus particularity ＬＭＰ (virus incubate egg white) cell immunity dint weaker, is 7%s just for 0% ～s, but the healthy person come to a 16% ～s 22%.The original hair adopted "the antigen vaccine of the ＥＢ virus film", canned raise the sufferer's immunity dint, effectively stopped the virus of ＥＢ the sex appeal dye and reduce a nose to swallow relapse of cancerous occurrence and treatment empress.

According to understanding, the research personnel has already developped an a fewＬＭ Ｐ currently 1, ＬＭ the Ｐ be 2 vaccines, is turning into a clinical trial stage in the application.